Table 4.
Model 1 | Model 2 | Model 3 | |
---|---|---|---|
Non-CKD subpopulation | |||
CS = 11 | reference | reference | reference |
CS = 9–10 | 1.51 (1.24–1.86) | 1.20 (0.99–1.47) | 1.19 (0.98–1.45) |
CS = 6–8 | 2.07 (1.64–2.60) | 1.25 (0.93–1.68) | 1.18 (0.89–1.56) |
CS = 0–5 | 3.58 (2.69–4.77) | 1.46 (1.07–2.01) | 1.39 (1.00–1.93) |
CKD subpopulation | |||
CS = 11 | reference | reference | reference |
CS = 9–10 | 1.41 (1.03–1.92) | 1.16 (0.83–1.62) | 1.14 (0.80–1.62) |
CS = 6–8 | 1.62 (1.16–2.26) | 1.24 (0.85–1.80) | 1.24 (0.85–1.80) |
CS = 0–5 | 3.47 (2.53–4.75) | 2.03 (1.16–3.55) | 2.02 (1.11–3.67) |
Model 1: Unadjusted.
Model 2: Adjusted for demographic factors, history of cardiovascular disease, hypertension, diabetes, physical inactivity, smoking, alcohol use, eGFR and albuminuria; stratified by gender and history of stroke.
Model 3: Model 2 variables plus CRP, hemoglobin, and serum 25-hydroxyvitamin D; stratified by gender and history of stroke.